Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation.

Buckner CM, Moir S, Ho J, Wang W, Posada JG, Kardava L, Funk EK, Nelson AK, Li Y, Chun TW, Fauci AS.

J Virol. 2013 May;87(10):5800-11. doi: 10.1128/JVI.00094-13. Epub 2013 Mar 13.

2.

B-lymphocyte dysfunction in chronic HIV-1 infection does not prevent cross-clade neutralization breadth.

Boliar S, Murphy MK, Tran TC, Carnathan DG, Armstrong WS, Silvestri G, Derdeyn CA.

J Virol. 2012 Aug;86(15):8031-40. doi: 10.1128/JVI.00771-12. Epub 2012 May 23.

3.

BCG-specific IgG-secreting peripheral plasmablasts as a potential biomarker of active tuberculosis in HIV negative and HIV positive patients.

Ashenafi S, Aderaye G, Zewdie M, Raqib R, Bekele A, Magalhaes I, Lema B, Habtamu M, Rekha RS, Aseffa G, Maeurer M, Aseffa A, Svensson M, Andersson J, Brighenti S.

Thorax. 2013 Mar;68(3):269-76. doi: 10.1136/thoraxjnl-2012-201817. Epub 2012 Aug 24.

4.

Circulating memory B cells and plasmablasts are associated with the levels of serum immunoglobulin in patients with ulcerative colitis.

Wang X, Jiang Y, Zhu Y, Zhang M, Li M, Wang H, Gao P.

J Cell Mol Med. 2016 May;20(5):804-14. doi: 10.1111/jcmm.12728. Epub 2016 Jan 22.

5.

Plasmablast-derived polyclonal antibody response after influenza vaccination.

He XS, Sasaki S, Narvaez CF, Zhang C, Liu H, Woo JC, Kemble GW, Dekker CL, Davis MM, Greenberg HB.

J Immunol Methods. 2011 Feb 28;365(1-2):67-75. doi: 10.1016/j.jim.2010.12.008. Epub 2010 Dec 21.

6.

Decreased mutation frequencies among immunoglobulin G variable region genes during viremic HIV-1 infection.

Bowers E, Scamurra RW, Asrani A, Beniguel L, MaWhinney S, Keays KM, Thurn JR, Janoff EN.

PLoS One. 2014 Jan 7;9(1):e81913. doi: 10.1371/journal.pone.0081913. eCollection 2014.

7.

Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection.

Cepok S, von Geldern G, Nolting T, Grummel V, Srivastava R, Zhou D, Hartung HP, Adams O, Arendt G, Hemmer B.

Ann Neurol. 2007 Nov;62(5):458-67.

PMID:
17703460
8.
9.

CXCR4/IgG-expressing plasma cells are associated with human gastrointestinal tissue inflammation.

Buckner CM, Moir S, Kardava L, Ho J, Santich BH, Kim LJ, Funk EK, Nelson AK, Winckler B, Chairez CL, Theobald-Whiting NL, Anaya-O'Brien S, Alimchandani M, Quezado MM, Yao MD, Kovacs JA, Chun TW, Fauci AS, Malech HL, De Ravin SS.

J Allergy Clin Immunol. 2014 Jun;133(6):1676-85.e5. doi: 10.1016/j.jaci.2013.10.050. Epub 2013 Dec 25.

10.

Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection.

De Milito A, Nilsson A, Titanji K, Thorstensson R, Reizenstein E, Narita M, Grutzmeier S, Sönnerborg A, Chiodi F.

Blood. 2004 Mar 15;103(6):2180-6. Epub 2003 Nov 6.

11.

Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies.

Doria-Rose NA, Klein RM, Manion MM, O'Dell S, Phogat A, Chakrabarti B, Hallahan CW, Migueles SA, Wrammert J, Ahmed R, Nason M, Wyatt RT, Mascola JR, Connors M.

J Virol. 2009 Jan;83(1):188-99. doi: 10.1128/JVI.01583-08. Epub 2008 Oct 15.

12.

Virus-specific antibody production and polyclonal B-cell activation in the intestinal mucosa of HIV-infected individuals.

Eriksson K, Kilander A, Hagberg L, Norkrans G, Holmgren J, Czerkinsky C.

AIDS. 1995 Jul;9(7):695-700.

PMID:
7546413
13.

Control of Viremia Enables Acquisition of Resting Memory B Cells with Age and Normalization of Activated B Cell Phenotypes in HIV-Infected Children.

Muema DM, Macharia GN, Hassan AS, Mwaringa SM, Fegan GW, Berkley JA, Nduati EW, Urban BC.

J Immunol. 2015 Aug 1;195(3):1082-91. doi: 10.4049/jimmunol.1500491. Epub 2015 Jun 26.

14.

Serum immunoglobulin G, M and A response to Cryptosporidium parvum in Cryptosporidium-HIV co-infected patients.

Kaushik K, Khurana S, Wanchu A, Malla N.

BMC Infect Dis. 2009 Nov 18;9:179. doi: 10.1186/1471-2334-9-179.

15.

Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals.

Kozlowski PA, Chen D, Eldridge JH, Jackson S.

AIDS Res Hum Retroviruses. 1994 Jul;10(7):813-22.

PMID:
7986587
16.

B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy.

Moir S, Buckner CM, Ho J, Wang W, Chen J, Waldner AJ, Posada JG, Kardava L, O'Shea MA, Kottilil S, Chun TW, Proschan MA, Fauci AS.

Blood. 2010 Dec 16;116(25):5571-9. doi: 10.1182/blood-2010-05-285528. Epub 2010 Sep 13.

17.

Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity.

Ruiz MJ, Ghiglione Y, Falivene J, Laufer N, Holgado MP, Socías ME, Cahn P, Sued O, Giavedoni L, Salomón H, Gherardi MM, Rodríguez AM, Turk G.

J Virol. 2016 Jan 15;90(2):670-81. doi: 10.1128/JVI.02363-15.

18.

IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity.

Black KP, Fultz PN, Girard M, Jackson S.

AIDS Res Hum Retroviruses. 1997 Oct 10;13(15):1263-72.

PMID:
9339843
19.

Vaccine-induced plasmablast responses in rhesus macaques: phenotypic characterization and a source for generating antigen-specific monoclonal antibodies.

Silveira EL, Kasturi SP, Kovalenkov Y, Rasheed AU, Yeiser P, Jinnah ZS, Legere TH, Pulendran B, Villinger F, Wrammert J.

J Immunol Methods. 2015 Jan;416:69-83. doi: 10.1016/j.jim.2014.11.003. Epub 2014 Nov 8.

20.

Reduced IgM levels and elevated IgG levels against oxidized low-density lipoproteins in HIV-1 infection.

Yilmaz A, Jennbacken K, Fogelstrand L.

BMC Infect Dis. 2014 Mar 17;14:143. doi: 10.1186/1471-2334-14-143.

Supplemental Content

Support Center